Form 4 for KNSA Kiniksa Pharmaceuticals International, plc
Accepted 2023-12-21 00:00:00 ET · period of report 2023-12-19 · accession 0001415889-23-016827 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-12-21 | 2023-12-19 | KNSA | Megna Michael R | CAO | S - Sale+OE | $19.13 | -9,316 | 17.0K | -35% | -$178.2K |
| D | 2023-12-21 | 2023-12-19 | KNSA | Megna Michael R | CAO | M - OptEx | $13.88 | +9,316 | 26.3K | +55% | +$129.3K |
| D | 2023-12-21 | 2023-12-19 | KNSA | Megna Michael R | CAO | M - OptEx | $0.00 | -9,316 | 20.7K | -31% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Share | 2023-12-19 | S | D | 9,316 | $19.13 | 17,005 | D | — | — | |
| 2 | Common | Class A Common Share | 2023-12-19 | M | A | 9,316 | $13.88 | 26,321 | D | — | — | |
| 3 | Derivative | Share Option | 2023-12-19 | M | D | 9,316 | $0.00 | 20,684 | D | $13.88 · — to 2028-08-05 | 9,316 Class A Common Share | (F2) This option is fully vested and exercisable. |